Natera stock: Roth/ MKM starts coverage with USD 475 target for Natera stock

Published on 10/23/2026 at 15:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q2 revenue rose 37.70 percent to USD 752.8 million. Natera stock costs EUR 357.60 on October 23, 2026, at a USD 57.2 billion market value for the company.

Roth/MKM target and results

Roth/MKM initiated coverage with a USD 475.00 target on October 23, 2026.
Natera reported Q2 2026 revenue of USD 752.8 million, up 37.70 percent year over year.
Natera stock stood at EUR 357.60 at Lang & Schwarz on October 23, 2026 at 3:32 p.m. CEST.
Natera is scheduled to report third-quarter results on November 5, 2026.

NTRA, US6323071042, Illustration mit AI erstellt.

Roth/MKM initiated coverage of Natera with a USD 475.00 price target on October 23, 2026, while Natera stock stood at EUR 357.60 at Lang & Schwarz at 3:32 p.m. CEST. The analyst action gives investors a fresh valuation marker as the diagnostics company approaches its next quarterly report.

Roth/MKM sees oncology potential

According to Investing.com on October 23, 2026, Roth/MKM began coverage with a Buy rating and a USD 475.00 target. The firm cited Natera's oncology diagnostics pipeline and pointed to future growth in minimal residual disease testing.

The target is a valuation reference in US dollars, separate from the euro quotation in Germany. Investing.com reported a USD 401.37 US-market price in its coverage, but that figure does not replace the Lang & Schwarz price used here.

Second-quarter growth remains central

Yahoo Finance reported on October 20, 2026, that Natera's second-quarter revenue rose 37.70 percent year over year to USD 752.8 million. Gross margin increased to 64.5 percent from 63.4 percent, while oncology tests rose 57.2 percent to approximately 296,700.

The same report said Natera narrowed its operating loss to USD 75.8 million from USD 110.4 million in the year-earlier quarter. Management also raised full-year 2026 revenue guidance by USD 100.0 million at the midpoint to USD 2.85 billion to USD 2.91 billion.

Market value and reporting date

Natera's market capitalization was USD 57.2 billion as of October 23, 2026, based on the Nasdaq quotation. Its 52-week range was USD 181.00 to USD 437.41, placing the latest US-market price below the yearly high while the company remains loss-making.

MarketBeat lists November 5, 2026, after the market close, as Natera's next estimated reporting date. Its consensus calls for third-quarter revenue of USD 707.67 million and a loss of USD 0.2697 per share.

What does the target imply?

Roth/MKM's USD 475.00 target sits above the current US quotation, but Natera's negative earnings keep revenue growth and margin conversion at the center of the valuation debate. The next report will test whether the second-quarter expansion continued into the third quarter.

Stock price stays in focus

Natera stock was trading at EUR 357.60 at Lang & Schwarz on October 23, 2026 at 3:32 p.m. CEST. The euro price provides the German-market view, while the Nasdaq listing and US-dollar analyst target provide the primary market context.

The further course of trading is shown by the continuously updated real-time quote of Natera stock.